1. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes;Gagan;Curr. Pharmaceut. Des.,2019
2. Development of electrochemical genosensors applied to cardiovascular pharmacogenetics;Morais;CSAC2021,2021
3. Cardiovascular disease in Europe 2014: epidemiological update;Nichols;Eur. Heart J.,2014
4. CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients;Panchenko;Pharmacogenomics J.,2020
5. Defining “mutation” and “polymorphism” in the era of personal genomics;Karki;BMC Med. Genom.,2015